Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS44015516
Basic Information
VIS ID
TVIS44015516
Fusion event
HTLV-1-VAV3 integration
Validated
No
Detection method
HTS
Data source
download(RID)
Sample type
Nontumor
Disease
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29186194
Virus Sequence
Virus name
HTLV-1
Reference genome
Not given
Host Sequence
Chromosome
chr1
Cytoband
p13.3
Reference genome
GRCh37/hg19
Start
108499745/107957123 (Hg38)
End
108499745/107957123 (Hg38)
Orient
-
Location type
Intronic
Target gene
VAV3
miRNAs that regulate target gene
hsa-mir-193b-3p
;
hsa-mir-186-5p
;
hsa-mir-98-5p
;
hsa-mir-149-5p
;
hsa-mir-27a-5p
;
hsa-mir-4290
;
hsa-mir-378g
;
hsa-mir-939-3p
;
hsa-mir-6791-5p
;
hsa-mir-4292
;
hsa-mir-4667-3p
;
hsa-mir-6779-3p
;
hsa-mir-28-3p
;
hsa-mir-4432
;
hsa-mir-185-3p
;
hsa-mir-762
;
hsa-mir-5001-5p
;
hsa-mir-4498
;
hsa-mir-6787-5p
;
hsa-mir-4492
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-4508
;
hsa-mir-5089-3p
;
hsa-mir-500a-3p
;
hsa-mir-760
;
hsa-mir-8072
;
hsa-mir-3194-3p
;
hsa-mir-6804-3p
;
hsa-mir-3960
;
hsa-mir-18a-3p
;
hsa-mir-324-3p
;
hsa-mir-1913
;
hsa-mir-4793-3p
;
hsa-mir-3130-3p
;
hsa-mir-6741-3p
;
hsa-mir-455-5p
;
hsa-mir-6079
;
hsa-mir-6763-3p
;
hsa-mir-513b-5p
;
hsa-mir-6789-3p
;
hsa-mir-671-5p
;
hsa-mir-6828-5p
;
hsa-mir-2115-5p
;
hsa-mir-6886-3p
;
hsa-mir-938
;
hsa-mir-6799-3p
;
hsa-mir-3173-5p
;
hsa-mir-6846-3p
;
hsa-mir-7706
;
hsa-mir-4680-5p
;
hsa-mir-7110-3p
;
hsa-mir-6845-3p
;
hsa-mir-3925-3p
;
hsa-mir-766-3p
;
hsa-mir-4315
;
hsa-mir-6769b-3p
;
hsa-mir-4723-3p
;
hsa-mir-3183
;
hsa-mir-6784-5p
;
hsa-mir-6752-3p
;
hsa-mir-4532
;
hsa-mir-5587-3p
;
hsa-mir-4707-5p
;
hsa-mir-6837-5p
;
hsa-mir-4685-5p
;
hsa-mir-7113-5p
;
hsa-mir-4673
;
hsa-mir-4645-5p
;
hsa-mir-125b-2-3p
;
hsa-mir-4457
;
hsa-mir-525-3p
;
hsa-mir-524-3p
;
hsa-mir-4428
;
hsa-mir-4511
;
hsa-mir-3133
;
hsa-mir-573
;
hsa-mir-3616-5p
;
hsa-mir-519e-5p
;
hsa-mir-515-5p
;
hsa-mir-4665-3p
;
hsa-mir-4436b-5p
;
hsa-mir-23c
;
hsa-mir-23b-3p
;
hsa-mir-23a-3p
;
hsa-mir-130a-5p
;
hsa-mir-7114-3p
;
hsa-mir-1180-5p
;
hsa-mir-3664-3p
;
hsa-mir-7107-5p
;
hsa-mir-1234-3p
;
hsa-mir-5088-3p
;
hsa-mir-5000-3p
;
hsa-mir-4436a
;
hsa-mir-4717-3p
;
hsa-mir-4802-3p
;
hsa-mir-4435
;
hsa-mir-525-5p
;
hsa-mir-520a-5p
;
hsa-mir-6743-3p
;
hsa-mir-3670
;
hsa-mir-6511b-3p
;
hsa-mir-6511a-3p
;
hsa-mir-4733-3p
;
hsa-mir-1226-3p
;
hsa-mir-4482-3p
;
hsa-mir-4670-3p
;
hsa-mir-4518
;
hsa-mir-1266-5p
;
hsa-mir-138-2-3p
;
hsa-mir-6809-3p
;
hsa-mir-4753-3p
;
hsa-mir-2117
;
hsa-mir-130b-5p
;
hsa-mir-148a-5p
;
hsa-mir-3912-5p
;
hsa-mir-6842-3p
;
hsa-mir-647
;
hsa-mir-1226-5p
;
hsa-mir-6771-5p
;
hsa-mir-425-3p
;
hsa-mir-6084
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-4529-5p
;
hsa-mir-196a-3p
;
hsa-mir-7160-5p
;
hsa-mir-214-5p
;
hsa-mir-4721
;
hsa-mir-3616-3p
;
hsa-mir-4539
;
hsa-mir-4685-3p
;
hsa-mir-4287
;
hsa-mir-6078
;
hsa-mir-6748-3p
;
hsa-mir-6832-3p
;
hsa-mir-6785-3p
;
hsa-mir-6733-3p
;
hsa-mir-892c-5p
;
hsa-mir-15a-3p
;
hsa-mir-30e-3p
;
hsa-mir-30d-3p
;
hsa-mir-30a-3p
;
hsa-mir-3127-5p
;
hsa-mir-199b-5p
;
hsa-mir-199a-5p
;
hsa-mir-1825
;
hsa-mir-6798-5p
;
hsa-mir-1250-3p
;
hsa-mir-6783-5p
;
hsa-mir-3178
;
hsa-mir-4634
;
hsa-mir-6499-5p
;
hsa-mir-6892-3p
;
hsa-mir-6840-5p
;
hsa-mir-6865-3p
;
hsa-mir-6856-3p
;
hsa-mir-449b-5p
;
hsa-mir-449a
;
hsa-mir-34c-5p
;
hsa-mir-34a-5p
;
hsa-mir-6499-3p
;
hsa-mir-498
;
hsa-mir-561-5p
;
hsa-mir-499a-5p
Nearest miRNA
hsa-mir-101-1/Upstream/59819; hsa-mir-11399/Downstream/1641770;
Nearest TSS
ENST00000473358/Upstream/136227;
ENST00000438318/Downstream/6377;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/476303
,
chr1-CpG: 97/Downstream/7506
Nearest cancer related gene
VAV3
(OG, No orient, 0)
Upstream sequence
aaacccaaaagaaaggggtattaagagagtgggatgcatgaaactgagaagagagagggtaactggtaataacTTCCAACTCAGAGTCCAAGACAGAATG
Downstream sequence
TGTTCCCTTTCTCACTAAAATGTGCCCCTTCTTTATGACACTTCTGTCACCTGATGCTGAAACCTGGGTCTCAACCTAGATACTTTCCACTCTTTCTCTG
Reference
Furuta, R., et al.Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathog,2017,13(11): e1006722.
Sample Information
×
Sample name
HAM/TSP#1
Sample type
Nontumor
Gender
Female
CpG Island Information
×
Download
Curate